Home CHMP Issues Positive Opinion for Tablet Formulation of Merck's NOXAFIL
 

Keywords :   


CHMP Issues Positive Opinion for Tablet Formulation of Merck's NOXAFIL

2014-03-01 00:42:42| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency recipients with graft-versus-host disease or those with hematologic malignancies with prolonged neutropenia from chemotherapy.

Tags: issues positive opinion formulation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
More »